Stryker Corporation (SYK) : Eubel Brady Suttman Asset Management Inc reduced its stake in Stryker Corporation by 3.07% during the most recent quarter end. The investment management company now holds a total of 101,121 shares of Stryker Corporation which is valued at $11,686,554 after selling 3,208 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Stryker Corporation makes up approximately 3.95% of Eubel Brady Suttman Asset Management Inc’s portfolio.
Other Hedge Funds, Including , Transamerica Financial Advisors sold out all of its stake in SYK during the most recent quarter. The investment firm sold 350 shares of SYK which is valued $40,450.Notis-mcconarty Edward reduced its stake in SYK by selling 25 shares or 0.32% in the most recent quarter. The Hedge Fund company now holds 7,695 shares of SYK which is valued at $889,003. Stryker Corporation makes up approx 0.60% of Notis-mcconarty Edward’s portfolio.Agf Investments reduced its stake in SYK by selling 1,500 shares or 46.88% in the most recent quarter. The Hedge Fund company now holds 1,700 shares of SYK which is valued at $195,194.Martin Investment Management reduced its stake in SYK by selling 29,546 shares or 13.56% in the most recent quarter. The Hedge Fund company now holds 188,353 shares of SYK which is valued at $22,042,952. Stryker Corporation makes up approx 3.56% of Martin Investment Management’s portfolio.Professional Advisory Services Inc boosted its stake in SYK in the latest quarter, The investment management firm added 24,045 additional shares and now holds a total of 148,117 shares of Stryker Corporation which is valued at $18,013,990. Stryker Corporation makes up approx 4.01% of Professional Advisory Services Inc’s portfolio.
Stryker Corporation opened for trading at $114.44 and hit $116.39 on the upside on Monday, eventually ending the session at $116.28, with a gain of 1.61% or 1.84 points. The heightened volatility saw the trading volume jump to 16,68,588 shares. Company has a market cap of $43,524 M.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.